These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

436 related items for PubMed ID: 20388846

  • 1. Combined functional genome survey of therapeutic targets for hepatocellular carcinoma.
    Satow R, Shitashige M, Kanai Y, Takeshita F, Ojima H, Jigami T, Honda K, Kosuge T, Ochiya T, Hirohashi S, Yamada T.
    Clin Cancer Res; 2010 May 01; 16(9):2518-28. PubMed ID: 20388846
    [Abstract] [Full Text] [Related]

  • 2. Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray.
    Li Y, Tang Y, Ye L, Liu B, Liu K, Chen J, Xue Q.
    J Cancer Res Clin Oncol; 2003 Jan 01; 129(1):43-51. PubMed ID: 12618900
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3.
    Li WC, Ye SL, Sun RX, Liu YK, Tang ZY, Kim Y, Karras JG, Zhang H.
    Clin Cancer Res; 2006 Dec 01; 12(23):7140-8. PubMed ID: 17145839
    [Abstract] [Full Text] [Related]

  • 4. Aberrant splicing of Hugl-1 is associated with hepatocellular carcinoma progression.
    Lu X, Feng X, Man X, Yang G, Tang L, Du D, Zhang F, Yuan H, Huang Q, Zhang Z, Liu Y, Strand D, Chen Z.
    Clin Cancer Res; 2009 May 15; 15(10):3287-96. PubMed ID: 19447873
    [Abstract] [Full Text] [Related]

  • 5. Sex-based molecular profiling of hepatitis C virus-related hepatocellular carcinoma.
    Takemoto N, Iizuka N, Yamada-Okabe H, Hamada K, Tamesa T, Okada T, Hashimoto K, Sakamoto K, Takashima M, Miyamoto T, Uchimura S, Hamamoto Y, Oka M.
    Int J Oncol; 2005 Mar 15; 26(3):673-8. PubMed ID: 15703822
    [Abstract] [Full Text] [Related]

  • 6. Identification of cystatin B as a potential serum marker in hepatocellular carcinoma.
    Lee MJ, Yu GR, Park SH, Cho BH, Ahn JS, Park HJ, Song EY, Kim DG.
    Clin Cancer Res; 2008 Feb 15; 14(4):1080-9. PubMed ID: 18281540
    [Abstract] [Full Text] [Related]

  • 7. Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype.
    Frau M, Ladu S, Calvisi DF, Simile MM, Bonelli P, Daino L, Tomasi ML, Seddaiu MA, Feo F, Pascale RM.
    J Hepatol; 2011 Jul 15; 55(1):111-9. PubMed ID: 21419759
    [Abstract] [Full Text] [Related]

  • 8. Identification of carboxypeptidase of glutamate like-B as a candidate suppressor in cell growth and metastasis in human hepatocellular carcinoma.
    Zhang P, Chan DW, Zhu Y, Li JJ, Ng IO, Wan D, Gu J.
    Clin Cancer Res; 2006 Nov 15; 12(22):6617-25. PubMed ID: 17121880
    [Abstract] [Full Text] [Related]

  • 9. Central genetic alterations common to all HCV-positive, HBV-positive and non-B, non-C hepatocellular carcinoma: a new approach to identify novel tumor markers.
    Kurokawa Y, Honma K, Takemasa I, Nakamori S, Kita-Matsuo H, Motoori M, Nagano H, Dono K, Ochiya T, Monden M, Kato K.
    Int J Oncol; 2006 Feb 15; 28(2):383-91. PubMed ID: 16391793
    [Abstract] [Full Text] [Related]

  • 10. Re-expression of transcription factor ATF5 in hepatocellular carcinoma induces G2-M arrest.
    Gho JW, Ip WK, Chan KY, Law PT, Lai PB, Wong N.
    Cancer Res; 2008 Aug 15; 68(16):6743-51. PubMed ID: 18701499
    [Abstract] [Full Text] [Related]

  • 11. Gene expression profiling of human HBV- and/or HCV-associated hepatocellular carcinoma cells using expressed sequence tags.
    Yoon SY, Kim JM, Oh JH, Jeon YJ, Lee DS, Kim JH, Choi JY, Ahn BM, Kim S, Yoo HS, Kim YS, Kim NS.
    Int J Oncol; 2006 Aug 15; 29(2):315-27. PubMed ID: 16820872
    [Abstract] [Full Text] [Related]

  • 12. Identification of novel aberrant methylation of BASP1 and SRD5A2 for early diagnosis of hepatocellular carcinoma by genome-wide search.
    Moribe T, Iizuka N, Miura T, Stark M, Tamatsukuri S, Ishitsuka H, Hamamoto Y, Sakamoto K, Tamesa T, Oka M.
    Int J Oncol; 2008 Nov 15; 33(5):949-58. PubMed ID: 18949357
    [Abstract] [Full Text] [Related]

  • 13. [Experimental observation on the alteration of metastatic potential and its gene function net of residual hepatocellular carcinoma following palliative liver resection].
    Huang XY, Huang ZL, Tang ZY, Xu B, Zheng Q, Zhou J, Wang L, Ye SL.
    Zhonghua Yi Xue Za Zhi; 2010 May 11; 90(18):1278-82. PubMed ID: 20646604
    [Abstract] [Full Text] [Related]

  • 14. Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
    Nardone G, Romano M, Calabrò A, Pedone PV, de Sio I, Persico M, Budillon G, Bruni CB, Riccio A, Zarrilli R.
    Hepatology; 1996 Jun 11; 23(6):1304-12. PubMed ID: 8675143
    [Abstract] [Full Text] [Related]

  • 15. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis.
    Nomoto S, Kanda M, Okamura Y, Nishikawa Y, Qiyong L, Fujii T, Sugimoto H, Takeda S, Nakao A.
    Ann Surg Oncol; 2010 Mar 11; 17(3):923-32. PubMed ID: 19898900
    [Abstract] [Full Text] [Related]

  • 16. Gene expression profiling of fixed tissues identified hypoxia-inducible factor-1α, VEGF, and matrix metalloproteinase-2 as biomarkers of lymph node metastasis in hepatocellular carcinoma.
    Xiang ZL, Zeng ZC, Fan J, Tang ZY, Zeng HY, Gao DM.
    Clin Cancer Res; 2011 Aug 15; 17(16):5463-72. PubMed ID: 21712445
    [Abstract] [Full Text] [Related]

  • 17. Granulin-epithelin precursor overexpression promotes growth and invasion of hepatocellular carcinoma.
    Cheung ST, Wong SY, Leung KL, Chen X, So S, Ng IO, Fan ST.
    Clin Cancer Res; 2004 Nov 15; 10(22):7629-36. PubMed ID: 15569995
    [Abstract] [Full Text] [Related]

  • 18. HTPAP gene on chromosome 8p is a candidate metastasis suppressor for human hepatocellular carcinoma.
    Wu X, Jia HL, Wang YF, Ren N, Ye QH, Sun HC, Wang L, Liu YK, Tang ZY, Qin LX.
    Oncogene; 2006 Mar 16; 25(12):1832-40. PubMed ID: 16261160
    [Abstract] [Full Text] [Related]

  • 19. RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County.
    Xue WJ, Li C, Zhou XJ, Guan HG, Qin L, Li P, Wang ZW, Qian HX.
    J Gastroenterol Hepatol; 2008 Sep 16; 23(9):1448-58. PubMed ID: 17683489
    [Abstract] [Full Text] [Related]

  • 20. [Experimental research of targeting hTERT gene inhibited in hepatocellular carcinoma therapy by RNA interference].
    Zhang PH, Tu ZG, Yang MQ, Huang WF, Zou L, Zhou YL.
    Ai Zheng; 2004 Jun 16; 23(6):619-25. PubMed ID: 15191658
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.